Last10K.com

Equillium, Inc. (EQ) SEC Filing 8-K Material Event for the period ending Monday, September 30, 2019

Equillium, Inc.

HISTORY TOOLS
CIK: 1746466 Ticker: EQ

View differences made from one to another to evaluate Equillium, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Equillium, Inc..

Continue

Assess how Equillium, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Equillium, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Equillium, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Exhibit 99.2: Additional Exhibits
Ticker: EQ
CIK: 1746466
Form Type: 8-K Corporate News
Accession Number: 0001564590-19-036089
Submitted to the SEC: Tue Oct 01 2019 4:10:27 PM EST
Accepted by the SEC: Tue Oct 01 2019
Period: Monday, September 30, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. New Agreement
  3. New Financial Obligation
  4. Other Events
  5. Regulated Disclosure
  6. Unregistered Sales

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/eq/0001564590-19-036089.htm